News
-
ACLA Commends House Appropriations Committee for Including Language in Agriculture-FDA Spending Bill Report Directing FDA To Suspend Draft Guidance to Regulate LDTs
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) today applauded House Appropriations Committee Chairman Harold Rogers, R-KY and Subcommittee Chairman Robert B. Aderholt, R-AL, for including report language in the agriculture-FDA appropriations bill that directs the Food and Drug Administration (FDA) to suspend efforts to finalize the LDT guidance, and instead work with Congress to develop a new pathway to regulate LDTs. “TheContinue Reading »... -
ACLA Commends Chairman Tiberi, Reps. Pascrell and Meehan for Bipartisan House Ways and Means Committee Letter to CMS Calling for PAMA Implementation Delay
WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) today applauded House Ways and Means Health Subcommittee Chairman Pat Tiberi (R-OH), and his Ways and Means colleagues Bill Pascrell (D-NJ) and Pat Meehan (R-PA), along with 24 other committee members, for sending a bipartisan letter to Andy Slavitt, Acting Administrator for the Centers for Medicare & Medicaid Services (CMS), urging CMS to delay implementationContinue Reading »... -
Reps. Tiberi, Meehan and Pascrell Letter to CMS on Changes to PAMA Clinical Laboratory Fee Schedule
... -
The American Clinical Laboratory Association Announces the Election of its 2016 Board of Directors
(Washington, D.C.) – The American Clinical Laboratory Association (ACLA) today announced the election of the 2016 Board of Directors for the nation’s largest trade association representing clinical laboratories. Following ACLA’s annual conference on March 3, Board members elected to hold office are Quest Diagnostics Incorporated President & CEO Stephen H. Rusckowski, for a third consecutive year-long term as Chairman of the Board, Curtis A.Continue Reading »... -
ACLA Comments on Novitas DL34914, Assays of Vitamins and Metabolic Function
... -
The American Clinical Laboratory Association Announces the Promotion of Julie Khani to Executive Vice President
(Washington, D.C.) – The American Clinical Laboratory Association (ACLA) today announced the promotion of Julie Khani to Executive Vice President (EVP) by the ACLA Board of Directors for the nation’s leading organization representing clinical laboratories. Khani joined ACLA in the newly created position of Senior Vice President in 2013 to oversee the advocacy and policy operations and ACLA’s divisional vice presidents. In her newContinue Reading »... -
Congressional and Administration Leaders Address Clinical Laboratory Community on Legislative and Regulatory Initiatives Impacting Diagnostics at ACLA’s 21st Annual Conference
(Washington, D.C.) –The diagnostic community and the critical role it plays in patient diagnoses and treatment plans was the focal point of various presentations today as congressional, regulatory and administration leaders addressed meeting attendees at the American Clinical Laboratory Association’s (ACLA) 21st Annual Conference in Washington, DC. “Clinical laboratories are a critical part of the scientific innovation that has brought us to the forefrontContinue Reading »... -
ACLA Underscores Value of Diagnostic Innovation in the Administration’s FY 2017 Budget Billion Dollar Funding of Moonshot Initiative
(Washington, D.C.) – In a letter to Vice President Joe Biden following the administration’s release of the FY 2017 budget including a proposed billion dollar funding of the Moonshot initiative aimed at accelerating the effort to cure cancer, the American Clinical Laboratory Association (ACLA) emphasized the expanded role of diagnostic innovation in the research and treatment of cancer and urged the vice president toContinue Reading »... -
Letter sent to Vice-President Biden on the Cancer Moonshot Task Force
... -
Joint Statement from the Alliance For Integrity in Medicare Applauding Self-Referral Reform Proposal in the President’s FY 2017 Budget
...
